全文获取类型
收费全文 | 1835篇 |
免费 | 174篇 |
国内免费 | 175篇 |
专业分类
林业 | 40篇 |
农学 | 36篇 |
基础科学 | 7篇 |
15篇 | |
综合类 | 520篇 |
农作物 | 52篇 |
水产渔业 | 102篇 |
畜牧兽医 | 1393篇 |
园艺 | 6篇 |
植物保护 | 13篇 |
出版年
2024年 | 3篇 |
2023年 | 58篇 |
2022年 | 107篇 |
2021年 | 110篇 |
2020年 | 139篇 |
2019年 | 131篇 |
2018年 | 84篇 |
2017年 | 94篇 |
2016年 | 102篇 |
2015年 | 85篇 |
2014年 | 130篇 |
2013年 | 135篇 |
2012年 | 161篇 |
2011年 | 169篇 |
2010年 | 89篇 |
2009年 | 99篇 |
2008年 | 68篇 |
2007年 | 66篇 |
2006年 | 51篇 |
2005年 | 44篇 |
2004年 | 30篇 |
2003年 | 42篇 |
2002年 | 25篇 |
2001年 | 17篇 |
2000年 | 15篇 |
1999年 | 18篇 |
1998年 | 18篇 |
1997年 | 18篇 |
1996年 | 16篇 |
1995年 | 11篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 10篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1985年 | 1篇 |
1983年 | 2篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1956年 | 3篇 |
排序方式: 共有2184条查询结果,搜索用时 15 毫秒
1.
2.
Luke J. Tucker Christine S. Grant Malley A. Gautreaux Dhanush L. Amarasekara Nicholas C. Fitzkee Amol V. Janorkar Anandavalli Varadarajan Santanu Kundu Lauren B. Priddy 《Marine drugs》2021,19(3)
Thermosensitive chitosan hydrogels—renewable, biocompatible materials—have many applications as injectable biomaterials for localized drug delivery in the treatment of a variety of diseases. To combat infections such as Staphylococcus aureus osteomyelitis, localized antibiotic delivery would allow for higher doses at the site of infection without the risks associated with traditional antibiotic regimens. Fosfomycin, a small antibiotic in its own class, was loaded into a chitosan hydrogel system with varied beta-glycerol phosphate (β-GP) and fosfomycin (FOS) concentrations. The purpose of this study was to elucidate the interactions between FOS and chitosan hydrogel. The Kirby Bauer assay revealed an unexpected concentration-dependent inhibition of S. aureus, with reduced efficacy at the high FOS concentration but only at the low β-GP concentration. No effect of FOS concentration was observed for the planktonic assay. Rheological testing revealed that increasing β-GP concentration increased the storage modulus while decreasing gelation temperature. NMR showed that FOS was removed from the liquid portion of the hydrogel by reaction over 12 h. SEM and FTIR confirmed gels degraded and released organophosphates over 5 days. This work provides insight into the physicochemical interactions between fosfomycin and chitosan hydrogel systems and informs selection of biomaterial components for improving infection treatment. 相似文献
3.
Alginates are naturally occurring polysaccharides extracted from brown marine algae and bacteria. Being biocompatible, biodegradable, non-toxic and easy to gel, alginates can be processed into various forms, such as hydrogels, microspheres, fibers and sponges, and have been widely applied in biomedical field. The present review provides an overview of the properties and processing methods of alginates, as well as their applications in wound healing, tissue repair and drug delivery in recent years. 相似文献
4.
5.
6.
7.
8.
2015—2017年新疆动物源鼠伤寒沙门菌耐药性分析 总被引:1,自引:1,他引:0
为完善新疆动物源鼠伤寒沙门菌耐药的相关数据,为多重耐药病源菌的防控提供依据,本研究检测了2015—2017年新疆不同动物源鼠伤寒沙门菌的流行情况、耐药特性及耐药基因携带率。对经选择性培养基和特异性PCR鉴定的不同动物源鼠伤寒沙门菌,通过琼脂稀释法进行环丙沙星等12种抗菌药物的最小抑菌浓度测定,同时采用PCR方法测定耐药基因在鼠伤寒沙门菌中的携带情况。结果表明:从不同动物中共分离获得162株鼠伤寒沙门菌,分离率由高到低依次为宠物(犬和猫)、猪、羊、牛和鸡;药敏试验显示,不同动物源鼠伤寒沙门菌对环丙沙星、氨苄西林、四环素和氟苯尼考的耐药率80.0%,未检出对阿米卡星和磷霉素耐药的耐药菌株。从不同动物源分离的162株鼠伤寒沙门菌中有159株菌为多重耐药菌株,占98.1%;不同动物源鼠伤寒沙门菌多重耐药均以CIP-AMP-TET-FFC-SMZ 5耐谱型为主。经耐药基因分析,不同动物源鼠伤寒沙门菌耐药基因检出率为6.8%~97.4%,未检出blaSHV、qnrD、rmtB和mcr-1基因。综上,鼠伤寒沙门菌在新疆不同动物中流行率高,耐药现象严重,多重耐药菌株较多且耐药基因携带率高,部分不同动物源菌株间具有相同的耐药表型和耐药基因型。应加强畜牧业抗菌药物使用的管理制度,进而控制鼠伤寒沙门菌耐药性的发展趋势。 相似文献
9.
Carmela Gallo Giusi Barra Marisa Saponaro Emiliano Manzo Laura Fioretto Marcello Ziaco Genoveffa Nuzzo Giuliana dIppolito Raffaele De Palma Angelo Fontana 《Marine drugs》2020,18(12)
Immunotherapy takes advantage of the immune system to prevent, control, and eliminate neoplastic cells. The research in the field has already led to major breakthroughs to treat cancer. In this work, we describe a platform that integrates in vitro bioassays to test the immune response and direct antitumor effects for the preclinical discovery of anticancer candidates. The platform relies on the use of dendritic cells that are professional antigen-presenting cells (APC) able to activate T cells and trigger a primary adaptive immune response. The experimental procedure is based on two phenotypic assays for the selection of chemical leads by both a panel of nine tumor cell lines and growth factor-dependent immature mouse dendritic cells (D1). The positive hits are then validated by a secondary test on human monocyte-derived dendritic cells (MoDCs). The aim of this approach is the selection of potential immunotherapeutic small molecules from natural extracts or chemical libraries. 相似文献
10.
Marilia Barreca Virginia Span Alessandra Montalbano Mercedes Cueto Ana R. Díaz Marrero Irem Deniz Ayegül Erdoan Lada Luki Bilela Corentin Moulin Elisabeth Taffin-de-Givenchy Filippo Spriano Giuseppe Perale Mohamed Mehiri Ana Rotter Olivier P. Thomas Paola Barraja Susana P. Gaudêncio Francesco Bertoni 《Marine drugs》2020,18(12)
The marine environment is a rich source of biologically active molecules for the treatment of human diseases, especially cancer. The adaptation to unique environmental conditions led marine organisms to evolve different pathways than their terrestrial counterparts, thus producing unique chemicals with a broad diversity and complexity. So far, more than 36,000 compounds have been isolated from marine micro- and macro-organisms including but not limited to fungi, bacteria, microalgae, macroalgae, sponges, corals, mollusks and tunicates, with hundreds of new marine natural products (MNPs) being discovered every year. Marine-based pharmaceuticals have started to impact modern pharmacology and different anti-cancer drugs derived from marine compounds have been approved for clinical use, such as: cytarabine, vidarabine, nelarabine (prodrug of ara-G), fludarabine phosphate (pro-drug of ara-A), trabectedin, eribulin mesylate, brentuximab vedotin, polatuzumab vedotin, enfortumab vedotin, belantamab mafodotin, plitidepsin, and lurbinectedin. This review focuses on the bioactive molecules derived from the marine environment with anticancer activity, discussing their families, origin, structural features and therapeutic use. 相似文献